Literature DB >> 7554378

Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

M Blank1, Y Tomer, M Stein, J Kopolovic, A Wiik, P L Meroni, G Conforti, Y Shoenfeld.   

Abstract

Wegener's granulomatosis (WG) is a granulomatous necrotizing vasculitis associated with the presence of ANCA, predominantly directed against proteinase 3 (PR3). The titres of ANCA correlate with disease activity and titre increases may precede disease exacerbations. Previously, we have shown that it is possible to induce autoimmune disease (systemic lupus erythematosus (SLE) and anti-phospholipid syndrome) in naive mice following active immunization with human autoantibodies, namely anti-DNA and anti-cardiolipin, respectively. The mice developed first anti-autoantibodies and, after about 4 months anti-anti-autoantibodies (Ab3), simulating auto-antibodies (Ab1) in their binding activities, and their presence was associated with the development of disease manifestations, characteristic of the human disease. So far, there is no good animal model for WG. In the current study we have immunized mice with human ANCA with the aim of inducing experimental WG. In two separate studies 30 mice were immunized in their footpads with autoantigen-purified IgG fraction (ANCA) from the sera of two patients with untreated WG, emulsified in Freund's complete adjuvant, followed 3 weeks later by ANCA injection in PBS. In the first experiment mice immunized with ANCA developed sterile microabscesses in the lungs after 8 months, and died after 8-15 months. In the second experiment, mice immunized with ANCA developed after 4 months mouse ANCA, with specificity both to PR3 and to myeloperoxidase, as well as anti-endothelial autoantibodies (AECA), as shown by radioimmunoprecipitation. Pathologically, the immunized mice developed proteinuria but not haematuria, and histological sections of the lungs demonstrated mononuclear perivascular infiltration, while diffuse granular deposition of immunoglobulins was noted in the kidneys. Our results point to a pathogenic role of ANCA in WG, and confirm the importance of the idiotypic network in the etiopathogenesis of autoimmune conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554378      PMCID: PMC1553333          DOI: 10.1111/j.1365-2249.1995.tb06645.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  59 in total

1.  Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells.

Authors:  N Del Papa; P L Meroni; A Tincani; E N Harris; S S Pierangeli; W Barcellini; M O Borghi; G Balestrieri; C Zanussi
Journal:  Clin Exp Rheumatol       Date:  1992 Jan-Feb       Impact factor: 4.473

2.  HLA antigen frequencies and Wegener's granulomatosis.

Authors:  G E Murty; B T Mains; D Middleton; A P Maxwell; D A Savage
Journal:  Clin Otolaryngol Allied Sci       Date:  1991-10

Review 3.  Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?

Authors:  C G Kallenberg; J W Tervaert; F J van der Woude; R Goldschmeding; A E von dem Borne; J J Weening
Journal:  Immunol Today       Date:  1991-02

4.  Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).

Authors:  R Bakimer; P Fishman; M Blank; B Sredni; M Djaldetti; Y Shoenfeld
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells.

Authors:  N del Papa; P L Meroni; W Barcellini; A Sinico; A Radice; A Tincani; D D'Cruz; F Nicoletti; M O Borghi; M A Khamashta
Journal:  Clin Immunol Immunopathol       Date:  1992-06

6.  Human endothelial cells express integrin receptors on the luminal aspect of their membrane.

Authors:  G Conforti; C Dominguez-Jimenez; A Zanetti; M A Gimbrone; O Cremona; P C Marchisio; E Dejana
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

7.  Effects of aging on the induction of experimental systemic lupus erythematosus (SLE) in mice.

Authors:  Y Tomer; S Mendlovic; T Kukulansky; E Mozes; Y Shoenfeld; A Globerson
Journal:  Mech Ageing Dev       Date:  1991-05       Impact factor: 5.432

8.  Wegener granulomatosis: an analysis of 158 patients.

Authors:  G S Hoffman; G S Kerr; R Y Leavitt; C W Hallahan; R S Lebovics; W D Travis; M Rottem; A S Fauci
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

9.  Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.

Authors:  D P D'Cruz; F A Houssiau; G Ramirez; E Baguley; J McCutcheon; J Vianna; H J Haga; G T Swana; M A Khamashta; J C Taylor
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 10.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

View more
  13 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 4.  ANCA testing. New developments and clinical implications.

Authors:  A E Ahmed; J B Peter; Y Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 5.  The clinical utility of ANCA positivity.

Authors:  J D Edgar
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 6.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 7.  New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation.

Authors:  Y Shoenfeld; I Krause; M Blank
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

8.  Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

Authors:  V C Primo; S Marusic; C C Franklin; W H Goldmann; C G Achaval; R N Smith; M A Arnaout; B Nikolic
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

9.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

10.  Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.

Authors:  A Kenderov; V Minkova; D Mihailova; N Giltiay; S Kyurkchiev; I Kehayov; M Kazatchkine; S Kaveri; A Pashov
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.